\-\ Texto\\:\\ \ \(0\)\
\-\ pending\\ surgical\\ planning\ \(0\)\
\-\ erythematous\\ patch\\,\\ sharply\\ demarcated\\ and\\ infiltrated\\ nipple\\.\ \(0\)\
\-\ paget\\ disease\\ of\\ the\\ breast\ \(0\)\
\-\ amyloidosis\\,\\ nodular\\ localized\\ cutaneous\\ \ \(0\)\
\-\ bowen\\ disease\\ \ \(0\)\
\-\ contact\\ dermatitis\\,\\ irritant\\ \ \(0\)\
\-\ drug\\ eruptions\\ \ \(0\)\
\-\ malignant\\ melanoma\\ \ \(3\)\
\-\ nipple\\ duct\\ adenoma\ \(0\)\
\-\ erosive\\ adenomatosis\\ of\\ the\\ nipple\\ \\ \ \(0\)\
\-\ benign\\ toker\\ cell\\ \\(clear\\ cell\\ of\\ the\\ nipple\\ epidermis\\)\\ hyperplasia\ \(0\)\
\-\ 43\\ y\\.o\\.\\ female\\ with\\ history\\ of\\ nipple\\ \\"eczema\\"\\ for\\ \\"years\\.\\"\\ \\ the\\ patient\\ reports\\ worsening\\ over\\ the\\ past\\ few\\ months\\.\\ \\ punch\\ biopsy\\ of\\ the\\ skin\\ revealed\\ paget\\ disease\\ of\\ breast\\.\ \(0\)\
\-\ the\\ patient\\ has\\ the\\ classic\\ presentation\\ of\\ paget\\ disease\\ of\\ the\\ breast\\ with\\ chronic\\ eczematous\\ disease\\ of\\ the\\ nipple\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ nipple\\:\\ 0\\.5869998079551497\ \(0\)\
\-\ paget\\:\\ 0\\.27526680983677826\ \(0\)\
\-\ breast\\:\\ 0\\.20157208556761536\ \(0\)\
\-\ disease\\:\\ 0\\.19419852337326585\ \(0\)\
\-\ the\\:\\ 0\\.18462563873486923\ \(0\)\
\-\ of\\:\\ 0\\.16296477845988042\ \(0\)\
\-\ bowen\\:\\ 0\\.14797141478838877\ \(0\)\
\-\ adenomatosis\\:\\ 0\\.14797141478838877\ \(0\)\
\-\ toker\\:\\ 0\\.14797141478838877\ \(0\)\
\-\ eczematous\\:\\ 0\\.14797141478838877\ \(0\)\
\-\ eruptions\\:\\ 0\\.14139458645225988\ \(0\)\
\-\ irritant\\:\\ 0\\.13672825248649623\ \(0\)\
\-\ eczema\\:\\ 0\\.1276510300625708\ \(0\)\
\-\ infiltrated\\:\\ 0\\.12031962592964338\ \(0\)\
\-\ punch\\:\\ 0\\.12031962592964338\ \(0\)\
\-\ epidermis\\:\\ 0\\.11760993275085153\ \(0\)\
\-\ dermatitis\\:\\ 0\\.11145443860996028\ \(0\)\
\-\ patch\\:\\ 0\\.11062243806235349\ \(0\)\
\-\ cell\\:\\ 0\\.10585984213677056\ \(0\)\
\-\ planning\\:\\ 0\\.10516470545878571\ \(0\)\
\-\ sharply\\:\\ 0\\.10459550830255258\ \(0\)\
\-\ demarcated\\:\\ 0\\.1035137438971645\ \(0\)\
\-\ amyloidosis\\:\\ 0\\.1020154066612564\ \(0\)\
\-\ contact\\:\\ 0\\.10154521563842804\ \(0\)\
\-\ erosive\\:\\ 0\\.09820620176012652\ \(0\)\
\-\ cutaneous\\:\\ 0\\.09608748303486027\ \(0\)\
\-\ erythematous\\:\\ 0\\.09392154315689318\ \(0\)\
\-\ 43\\:\\ 0\\.08659013902396574\ \(0\)\
\-\ melanoma\\:\\ 0\\.08640685510213467\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.0843552247493783\ \(0\)\
\-\ drug\\:\\ 0\\.08419541602323495\ \(0\)\
\-\ localized\\:\\ 0\\.08311878223768936\ \(0\)\
\-\ duct\\:\\ 0\\.07964879075207427\ \(0\)\
\-\ few\\:\\ 0\\.07848969387840983\ \(0\)\
\-\ pending\\:\\ 0\\.07610155251887174\ \(0\)\
\-\ adenoma\\:\\ 0\\.07376752352533401\ \(0\)\
\-\ nodular\\:\\ 0\\.07368412768868733\ \(0\)\
\-\ reports\\:\\ 0\\.07195019686945396\ \(0\)\
\-\ worsening\\:\\ 0\\.07065761868644396\ \(0\)\
\-\ classic\\:\\ 0\\.06920604095567924\ \(0\)\
\-\ skin\\:\\ 0\\.06883170616190203\ \(0\)\
\-\ clear\\:\\ 0\\.0670795957514656\ \(0\)\
\-\ malignant\\:\\ 0\\.0659568097778473\ \(0\)\
\-\ biopsy\\:\\ 0\\.0648583902169792\ \(0\)\
\-\ presentation\\:\\ 0\\.06369430012963925\ \(0\)\
\-\ benign\\:\\ 0\\.06356006111935593\ \(0\)\
\-\ revealed\\:\\ 0\\.060669703240388395\ \(0\)\
\-\ past\\:\\ 0\\.060228303091990364\ \(0\)\
\-\ patient\\:\\ 0\\.060189019766943644\ \(0\)\
\-\ years\\:\\ 0\\.0567180423342105\ \(0\)\
\-\ chronic\\:\\ 0\\.05492160486923665\ \(0\)\
\-\ months\\:\\ 0\\.053858417695247233\ \(0\)\
\-\ over\\:\\ 0\\.05144928803711957\ \(0\)\
\-\ surgical\\:\\ 0\\.044971322158953796\ \(0\)\
\-\ female\\:\\ 0\\.044648725746982726\ \(0\)\
\-\ has\\:\\ 0\\.04226380856287108\ \(0\)\
\-\ with\\:\\ 0\\.036236033305817296\ \(0\)\
\-\ history\\:\\ 0\\.03535081346298655\ \(0\)\
\-\ for\\:\\ 0\\.02804433703512946\ \(0\)\
\-\ and\\:\\ 0\\.01911964909249818\ \(0\)\
